Neuron-specific enolase (NSE)


neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, pancreatic endocrine tumors, and melanoma.

Studies of NSE as a tumor marker have concentrated primarily on patients with neuroblastoma and small cell lung cancer. Measurement of NSE levels in patients with these two diseases can provide information about the extent of the disease and the patient’s prognosis (outlook), as well as about the patient’s response to treatment.

Read Also:

  • Neurooncologist

    A physician trained in surgery of the nervous system. These (and other types of) physicians may function as neurooncologists because oncology (the study of cancer) is a very large field with a considerable diversity of neural tumors and various ways to diagnose and treat them.

  • Neuropathic pain

    Chronic pain resulting from injury to the nervous system. The injury can be to the central nervous system (brain and spinal cord) or the peripheral nervous system (nerves outside the brain and spinal cord). Neuropathic pain can occur after trauma and many diseases such as multiple sclerosis and stroke. It is common and affects more […]

  • Neuropathologist

    A pathologist who specializes in the diagnosis of diseases of the brain and nervous system by microscopic examination of the tissue and other means.

  • Neuropathy

    Any disease or malfunction of the nerves.

  • Neuropathy, accessory

    A disease of the accessory nerve, paralysis of which prevents rotation of the head away from one or both sides and causes the shoulder to droop. Damage can be confined to the accessory nerve, or it may also involve the ninth and tenth cranial nerves, which exit the skull through the same opening.


Disclaimer: Neuron-specific enolase (NSE) definition / meaning should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. All content on this website is for informational purposes only.